SENU Venture Partners

Deep tech investing in the future of human experience and longevity.

Backing the builders commercializing technologies that expand human capability and extend healthy life.

  • Physical AI
  • Cybernetics
  • Acceleration Infrastructure
Day +1

01 · Why SENU

Long-standing technological limits are becoming engineering opportunities.

Humanity is entering a period defined by the convergence of AI, robotics, neuroscience, and biotechnology. SENU focuses on the transition point where validated science leaves the laboratory and becomes scalable, affordable products that help people live richer, longer lives.

We are not a discovery investor. We back companies where the science works and what remains is execution: engineering, cost, regulatory navigation, and adoption.

The next generation of enduring companies will be the ones that turn feasible science into products people can afford, embrace, and trust.

02 · Why Now

Intelligence is leaving the screen.

The first wave of AI lived in software. The next will act in the physical and biological world.

The hardest problems in human health are shifting from whether the science works to whether it can be built, sold, and scaled.

$27.6B

Robotics and physical AI venture funding in 2025, a record and more than double 2024.

PitchBook · 2025

1,451

AI-enabled medical devices authorized by the FDA through 2025, including a record 295 in 2025 alone.

U.S. FDA

2029

The year U.S. adults 65 and older are projected to outnumber children under 18 for the first time.

U.S. Census Bureau · 2023 projections

8.9M

U.S. direct-care job openings projected from 2022 to 2032.

PHI · BLS data

1.5B

People worldwide aged 65 or older by 2050.

UN DESA

36%

Deep tech's share of global venture funding in 2026, up from roughly 10% a decade earlier.

Celesta Capital · 2026

03 · Focus

Three categories that interlock.

Progress in one lowers the cost of progress in the others, and a company in any of the three tends to become a customer of the other two.

01

Physical AI

Intelligence that perceives and acts in the physical world: machines that do real work in manufacturing, logistics, laboratory, clinical, and care settings.

$35K → $13K to $17K

Humanoid robot bill of materials, 2025 to projected 2030.

Bank of America Institute

02

Cybernetics

The integration of people with engineered systems: human-machine interfaces, prosthetics and exoskeletons, assistive neurotechnology, and the digital systems that sustain cognition over longer lives.

Jan 2024

CMS classified exoskeleton devices under the Medicare brace benefit category.

CMS · CY2024 Home Health rule

03

HUMANROBOTSIM

Acceleration Infrastructure

The tooling and platforms that make the other two cheaper, faster, and more certain to build, turning high fixed costs into declining marginal costs.

9 months → 11 hours

Robot training data equal to nine months of human demonstration, generated in simulation in 11 hours. Mixed with real data, it lifted model performance 40%.

NVIDIA · 2025

04 · Our Approach

We are operators who invest, not investors who observe.

Our team has founded, scaled, hired, financed, and exited companies, and we bring that experience to the founders we work with.

Rather than acting solely as a source of capital, we work alongside builders on the things that actually determine outcomes:

  • Recruiting
  • Go-to-market
  • Regulatory pathways
  • Capital planning
  • Durable organizations

We treat ethics, trust, and adoption as first-order operating constraints.

We lead or co-lead Seed and Series A rounds and take an active role in the boardroom.

05 · Contact

Get in touch.

Founders taking validated science to market: we would like to hear from you.

© 2026 SENU Ventures Management, LLC